David G Maloney Selected Research

David G Maloney Research Topics

Disease

65	Neoplasms (Cancer) 04/2024 - 01/2002
32	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2024 - 09/2002
31	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 02/2002
29	Lymphoma (Lymphomas) 05/2024 - 05/2002
23	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 01/2003
23	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2003
20	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 01/2003
18	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 07/2006
13	Infections 12/2022 - 01/2002
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020 - 05/2002
10	Multiple Myeloma 09/2023 - 01/2003
9	Cytokine Release Syndrome 10/2023 - 11/2017
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 01/2003
7	Disease Progression 01/2023 - 06/2008
6	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 09/2008
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 09/2007
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 08/2011
5	Cytopenia 12/2022 - 12/2011
5	Neutropenia 12/2022 - 05/2003
5	Thrombocytopenia (Thrombopenia) 12/2022 - 05/2003
5	Residual Neoplasm 11/2019 - 01/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 02/2008
3	Leukemia 04/2024 - 10/2003
3	Agammaglobulinemia (Hypogammaglobulinemia) 10/2021 - 01/2020
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 01/2005
3	Pathologic Complete Response 02/2016 - 06/2005
2	Anemia 12/2022 - 12/2011
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 02/2008
2	Bronchiolitis Obliterans Syndrome 01/2015 - 10/2008
2	Lymphopenia (Lymphocytopenia) 05/2013 - 12/2004
2	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013 - 11/2008
2	Systemic Scleroderma (Systemic Sclerosis) 12/2008 - 12/2004
2	Multiple Sclerosis 12/2008 - 12/2004
2	Acute Kidney Injury (Acute Renal Failure) 03/2005 - 07/2004
2	Cytomegalovirus Infections (Inclusion Disease) 11/2003 - 03/2002

Drug/Important Bio-Agent (IBA)

44	Chimeric Antigen ReceptorsIBA 05/2024 - 11/2010
31	fludarabineIBA 01/2022 - 02/2003
29	Rituximab (Mabthera)FDA Link 10/2020 - 02/2002
11	Monoclonal AntibodiesIBA 01/2022 - 05/2002
10	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 03/2002
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 05/2002
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 03/2002
9	AntigensIBA 08/2019 - 03/2002
8	axicabtagene ciloleucelIBA 10/2023 - 01/2020
7	AntibodiesIBA 01/2023 - 02/2002
6	CD19-specific chimeric antigen receptorIBA 11/2019 - 01/2016
4	EpitopesIBA 05/2024 - 07/2011
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 05/2003
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 10/2014
3	CytokinesIBA 10/2023 - 01/2016
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 01/2021
3	tisagenlecleucelIBA 03/2022 - 01/2020
3	VaccinesIBA 01/2021 - 09/2005
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 05/2002
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 10/2010
3	Immunoglobulin G (IgG)IBA 01/2021 - 11/2019
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	IodineIBA 01/2018 - 09/2003
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2003
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 09/2003
3	TEMPOIBA 01/2015 - 12/2004
3	CD20 AntigensIBA 11/2014 - 02/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2014 - 02/2010
3	Complement System Proteins (Complement)IBA 02/2005 - 02/2002
2	Bortezomib (Velcade)FDA Link 09/2023 - 11/2017
2	venetoclaxIBA 01/2023 - 01/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022 - 12/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 09/2002
2	PlatinumIBA 01/2022 - 12/2015
2	Clofarabine (Clolar)FDA Link 01/2021 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 01/2019
2	Calcineurin InhibitorsIBA 01/2021 - 03/2012
2	ibrutinibIBA 01/2020 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 11/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 02/2015 - 07/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015 - 04/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010 - 02/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2006 - 08/2003
1	H antigenIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024
1	durvalumabIBA 10/2023
1	Bendamustine Hydrochloride FDA Link 10/2023
1	Vorinostat FDA Link 09/2023

Therapy/Procedure

74	Cell Transplantation 11/2022 - 02/2003
63	Therapeutics 04/2024 - 02/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
24	Transplantation 01/2021 - 03/2002
20	Stem Cell Transplantation 09/2023 - 03/2002
17	Immunotherapy 10/2023 - 09/2005
14	Homologous Transplantation 11/2022 - 01/2003
13	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2002
10	Radioimmunotherapy 11/2022 - 05/2002
4	Aftercare (After-Treatment) 12/2022 - 10/2015
4	Autologous Transplantation 12/2015 - 01/2002
2	Induction Chemotherapy 02/2016 - 06/2008
2	Radiotherapy 09/2006 - 09/2003
2	Ligation 02/2002 - 02/2002